Microbix Biosystems (TSE:MBX) Share Price Passes Below 50-Day Moving Average – Time to Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.23 and traded as low as C$0.23. Microbix Biosystems shares last traded at C$0.23, with a volume of 18,000 shares traded.

Microbix Biosystems Stock Performance

The company has a market capitalization of C$31.93 million, a P/E ratio of -14.38 and a beta of 0.15. The company has a debt-to-equity ratio of 22.61, a quick ratio of 5.57 and a current ratio of 7.15. The business’s fifty day simple moving average is C$0.23 and its 200-day simple moving average is C$0.25.

Microbix Biosystems (TSE:MBX) last posted its earnings results on Thursday, December 18th. The company reported C($0.01) EPS for the quarter. Microbix Biosystems had a return on equity of 12.65% and a net margin of 13.86%.The firm had revenue of C$3.74 million during the quarter. As a group, equities analysts anticipate that Microbix Biosystems Inc. will post 0.02 earnings per share for the current fiscal year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.